CNTX
Context Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$216.84M
P/E Ratio
—
EPS
$-0.42
Beta
1.57
52W High
$3.62
52W Low
$0.49
50-Day MA
$2.62
200-Day MA
$1.64
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Context Therapeutics Inc
Centrexion Therapeutics Corporation, a late-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of chronic pain. The company is headquartered in Boston, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-43.50M |
| Operating Margin | 0.00% |
| Return on Equity | -56.20% |
| Return on Assets | -35.80% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.57 |
| Price-to-Book | 4.19 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 1.60 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $91.88M |
| Float | $42.72M |
| % Insiders | 1.18% |
| % Institutions | 77.26% |
Historical Volatility
HV 10-Day
55.06%
HV 20-Day
76.01%
HV 30-Day
64.50%
HV 60-Day
85.02%
HV Rank
17.5%
Volatility is currently contracting
Analyst Ratings
Consensus ($6.00 target)
3
Strong Buy7
BuyMore HEALTHCARE Stocks
Data last updated: 5/14/2026